After Hetlioz’s rejection in jet lag disorder, Vanda sues FDA for right to promote off-label use

11th April 2025 Uncategorised 0

After years of back-and-forth with the FDA over Hetlioz’s potential use as a jet lag disorder treatment, Vanda Pharmaceuticals is pursuing a new route to establish the drug in the space.

More: After Hetlioz’s rejection in jet lag disorder, Vanda sues FDA for right to promote off-label use
Source: fierce